Mimicking the evolution of doxorubicin resistance in triple negative breast cancer

被引：0
作者：
Pearson, Kashenya
Everett, Terrence
Rorie, Checo J.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 10期
关键词：
D O I：
10.1158/1538-7445.EVODYN22-B030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B030
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
    Berry, Jameson T. L.
    Munoz, Luis E.
    Stewart, Roxana M. Rodriguez
    Selvaraj, Periasamy
    Mainou, Bernardo A.
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 556 - 572
  • [42] Evaluation of the Effect of Taurine and Doxorubicin Combination on Apoptosis and Metastasis in Triple Negative Breast Cancer
    Gedikli, Esra
    Dincsoy, Adnan Berk
    Erdem, Ilker Levent
    Karakoc, Elif
    Muftuoglu, Sevda
    Erdem, Aysen
    ACTA PHYSIOLOGICA, 2023, 240 : 67 - 68
  • [43] Cardiac metastasis of triple-negative breast cancer mimicking myxoma: A case report
    Mallapasi, Muhammad Nuralim
    Kusumanegara, Jayarasti
    Kabo, Peter
    Usman, Umar
    Mulyono, Mario Tri
    Faruk, Muhammad
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2021, 88
  • [44] Phase I trial combining pembrolizumab and doxorubicin in patients with metastatic triple negative breast cancer.Phase I trial combining pembrolizumab and doxorubicin in patients with metastatic triple negative breast cancer.
    Yuan, Yuan
    Ge, Xuan
    Yost, Susan Elaine
    Lee, Jin Sun
    Frankel, Paul Henry
    Ruel, Christopher
    Cui, Yujie
    Murga, Mireya
    Tang, Aileen
    Martinez, Norma
    Karimi, Misagh
    Somlo, George
    Mortimer, Joanne E.
    Waisman, James Ross
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] GRB7 promotes doxorubicin resistance in triple-negative breast cancer cells via multiple signaling pathways
    Lofgren, Kristopher A.
    Calvo, Veronica
    Giricz, Orsi
    Kenny, Paraic A.
    CANCER RESEARCH, 2015, 75
  • [46] The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
    Eduardo Tormo
    Sandra Ballester
    Anna Adam-Artigues
    Octavio Burgués
    Elisa Alonso
    Begoña Bermejo
    Silvia Menéndez
    Sandra Zazo
    Juan Madoz-Gúrpide
    Ana Rovira
    Joan Albanell
    Federico Rojo
    Ana Lluch
    Pilar Eroles
    Scientific Reports, 9
  • [47] The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
    Tormo, Eduardo
    Ballester, Sandra
    Adam-Artigues, Anna
    Burgues, Octavio
    Alonso, Elisa
    Bermejo, Begona
    Menendez, Silvia
    Zazo, Sandra
    Madoz-Gurpide, Juan
    Rovira, Ana
    Albanell, Joan
    Rojo, Federico
    Lluch, Ana
    Eroles, Pilar
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [48] Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein (vol 175, 105975, 2022)
    Abd-ellatef, Gamal Eldein Fathy
    Gazzano, Elena
    El-Desoky, Ahmed H.
    Hamed, Ahmed R.
    Kopecka, Joanna
    Belisario, Dimas Carolina
    Costamagna, Costanzo
    Marie, Mohamed Assem S.
    Fahmy, Sohair R.
    Abdel-Hamid, Abdel-Hamid Z.
    Riganti, Chiara
    PHARMACOLOGICAL RESEARCH, 2023, 189
  • [49] Utilizing a novel HDAC inhibitor bocodepsin (OKI-179) to overcome doxorubicin resistance in triple-negative breast cancer
    Smoots, Stephen G.
    Schreiber, Anna R.
    Jackson, Marilyn M.
    Dus, Evan D.
    Bagby, Stacey M.
    Dominguez, Adrian T. A.
    Binns, Cameron A.
    Diamond, Jennifer R.
    Pitts, Todd M.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [50] STK32C modulates doxorubicin resistance in triple-negative breast cancer cells via glycolysis regulation
    Xiao, Huawei
    Liu, Lei
    Huang, Shaoyan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025, 480 (01) : 459 - 471
12345